September 17, 2026
Agency will use the software platform to support modern cosmetic safety assessment through integrated exposure and toxicity modeling. RESEARCH TRIANGLE PARK, N.C. -- Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced that the U.S. Food and Drug Administration's [...]
September 17, 2026
New partnership pairs HighRes lab automation and Cellario® orchestration with Involve Data's data and AI strategy, closing the gap between the physical lab and the enterprise systems that depend on it. BEVERLY, Mass.-- HighRes®, the market leader in lab automation, and Involve Data, a data strategy firm for life sciences, today announced a partnership to [...]
Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery
September 16, 2026
Antibody characterization data generated by Twist supports TuneLab AI models designed to accelerate antibody discovery SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced an agreement with Lilly TuneLab, a collaborative AI/ML drug discovery platform created by Eli Lilly and Company (Lilly). Twist is a [...]
September 16, 2026
Six years after Seer’s foundational Nature Communications paper, researchers across three continents have built a growing body of evidence demonstrating the power of deep, unbiased proteomics across genetics, aging, disease biology and population health REDWOOD CITY, Calif. -- Seer, Inc. (Nasdaq: SEER), a pioneer in deep, unbiased proteomics, today announced that its Proteograph® Product Suite [...]
September 16, 2026
Göttingen, Germany | Dublin, Ireland Collaboration with National Institute for Bioprocessing Research and Training will enable practical training in next-generation biomanufacturing Facility will be equipped with end-to-end continuous process platform Pionic by Sartorius Partnership to strengthen global workforce readiness and accelerate industry transition toward more efficient and sustainable biopharmaceutical production The life science group Sartorius [...]
September 16, 2026
New Cas9 mRNA solutions from IDT and Aldevron provide researchers with high-performance, scalable gene editing tools designed to support faster progression from research to development. Co-developed offering connects Integrated DNA Technologies’ CRISPR engineering and analysis expertise with Aldevron’s mRNA manufacturing capabilities, helping customers move from discovery toward clinical development with greater speed, continuity, and confidence. [...]
September 16, 2026
New Tapestri® capability connects genotype, gene expression, and phenotype in the same cell, giving researchers a direct view of how genetic alterations shape cellular behavior. SOUTH SAN FRANCISCO, Calif. -- Mission Bio, a leader in single-cell multi-omics, today announced Tapestri® Triomics, a new expansion of the Tapestri Platform that simultaneously analyzes DNA, RNA, and protein [...]
September 16, 2026
Available now, this new proprietary dispensing capability lets customers order the exact single-use bag sizes and quantities their process requires, released as a single lot with one Certificate of Analysis, with no added turnaround time HOLLISTER, Calif. -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and [...]
September 16, 2026
New engineered enzyme and ready-to-use master mix combine rapid, sensitive cDNA synthesis with exceptional stability and simplified setup. Overview: As RNA research grows in scale and complexity, researchers need tools that can keep pace with more challenging samples and advanced analysis. Invitrogen™ SuperScript™ V Reverse Transcriptase is a next-generation engineered enzyme designed to make the [...]
September 15, 2026
Icahn School of Medicine at Mount Sinai, CNAG, Karolinska Institutet, and Stanford University will apply 3D spatial multi-omics across neuroscience, immunology, oncology, and tissue atlas research BOSTON -- Stellaromics, Inc., the leader in 3D spatial multi-omics, today announced the first commercial placements of its Pyxa® platform, the industry's first solution for true 3D spatial multi-omics [...]

